| Literature DB >> 24667590 |
Dina Kao1, Naomi Hotte, Patrick Gillevet, Karen Madsen.
Abstract
Inflammatory bowel disease (IBD) is a chronic relapsing disorder of the intestine of unclear etiology. Increasing evidence has pointed to intestinal dysbiosis as a potential factor in a genetically susceptible individual. Fecal microbiota transplantation (FMT) has been used to treat inflammatory bowel disease with variable degrees of success. Herein, we report a patient with Crohn's colitis, previously failing an immunosuppressant, who achieved clinical, endoscopic, and histologic remission after a single fecal microbiota transplantation infusion. We have further characterized the changes in the fecal microbiota associated with this observation.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24667590 DOI: 10.1097/MCG.0000000000000131
Source DB: PubMed Journal: J Clin Gastroenterol ISSN: 0192-0790 Impact factor: 3.062